drugset / Trial / NCT07636356
THCV Treatment for Smokers
Phase 2
Not yet recruiting
32 enrolled
University of California, Los Angeles
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverTriple-blindTreatment
Summary
This study will randomize 32 non-treatment-seeking individuals who smoke cigarettes daily into a randomized, crossover, double-blind, placebo-controlled study testing the safety, tolerability, and initial efficacy of Δ9-tetrahydrocannabivarin (Δ9-THCV).
Timeline
- Start
- 2026-07
- Primary completion
- 2028-05-31
- Completion
- 2028-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Δ9-Tetrahydrocannabivarin | Unknown | 10 mg | Oral |